Peter Ordentlich

Role: Chief Scientific Officer at Syndax Pharmaceuticals
Location: Lexington, MA, US
LinkedIn followers: 500 followers

Research & DevelopmentView LinkedIn profile

Experience

Chief Scientific Officer
Syndax Pharmaceuticals
Nov 2013 — Present

Contact information

Verified work emails, personal emails, and direct dials — unlocked in one click.

Work email
•••••@syndax.com
Personal email
•••••@•••••.com
Direct dial
+•• ••• ••• ••••

Unlock verified contacts

Free to start · No credit card required

Current company

Syndax Pharmaceuticals

Biotechnology Research · 331 employees · New York, New York, United States

Syndax Pharmaceuticals is a commercial-stage biopharmaceutical company advancing innovative cancer therapies. Highlights of the Company’s pipeline include a menin inhibitor for R/R acute leukemia and a monoclonal antibody that blocks the CSF-1 receptor for chronic graft-versus-host disease. Fueled by our commitment to reimagining cancer care, Syndax is working to unlock the full potential of its pipeline and is conducting several clinical trials across the continuum of treatment. Review our social media community guidelines below: https://syndax.com/social-media-community-guidelines/

syndax.com

Find verified contacts for anyone on LinkedIn

Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.

Start for free See how it works

Free plan included · No credit card required

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Experience

Chief Scientific Officer

Find verified contacts for anyone on LinkedIn